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The monoclonal antibody D2-40 is a specific lymphatic endothelial markers and D2-40 staining have been applicable to evaluate
lymphatic invasion in various malignant neoplasms. In the present study, we investigated lymph node micrometastasis determined by
immunohistochemistry (IHC) and reverse transcription–polymerase chain reaction (RT–PCR) in all dissected lymph nodes obtained
from 80 patients with node-negative gastric cancer, and analysed the relationship between micrometastasis and clinicopathological
findings including lymphatic invasion of the resected primary tumour using D2-40 immunohistochemical staining. The incidence of
micrometastasis determined by IHC and RT–PCR was 11.3% (nine out of 80) and 31.3% (25 out of 80), respectively. Although
haematoxylin–eosin (HE) staining revealed lymphatic invasion in 11.3% (nine out of 80) of patients, D2-40 staining uncovered new
invasion in 23.8% (19 out of 80) of patients. In the diagnosis of HE and D2-40 staining, the incidence of micrometastasis was
significantly higher in patients with lymphatic invasion than in those without lymphatic invasion (P¼0.0150 and Po0.0001,
respectively). Micrometastasis correlated more closely with D2-40 than with HE staining. We demonstrated a high incidence of
micrometastasis and lymphatic invasion and a correlation between them even in pN0 gastric cancer. When planning less invasive
treatment, the presence of such occult cancer cells should be considered.
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Lymph node metastasis is one of the most important prognostic
factors in patients with gastric cancer (Kwon and Kim, 1996; Nitti
et al, 2003). Therefore, radical lymphadenectomy for gastric cancer
has become a standard procedure, resulting in the long-term
survival of patients with lymph node metastasis (Maehara et al,
1992). Nevertheless, several authors have reported that complete
resection with radical lymphadenectomy that led to a node-
negative (pN0) final diagnosis according to routine histological
haematoxylin–eosin (HE) staining did not prevent recurrence
(Maehara et al, 1996; Siewert et al, 1996; Ishida et al, 1997). The
key causative factor of recurrent gastric cancer is lymph node
micrometastasis. The sentinel node (SN) concept has recently been
applied to gastrointestinal tract cancers including gastric cancer
(Saha et al, 2000; Aikou et al, 2001; Uenosono et al, 2003). During
sentinel node navigation surgery (SNNS), lymph node micro-
metastasis cannot be disregarded.
Lymph node micrometastasis can be detected because of
sensitive biological methods such as real-time reverse transcrip-
tion–polymerase chain reaction (RT–PCR). Some authors have
proven that RT–PCR can detect lymph node micrometastasis in
gastrointestinal tract or breast cancers (Mori et al, 1995;
Matsumoto et al, 2002). Circulating cancer cells in the bone
marrow or peripheral blood and free cancer cells in the peritoneal
lavage fluid have been detected by RT–PCR (Gerhard et al, 1994;
Burchill et al, 1995; Marutsuka et al, 2003). Thus, RT–PCR-based
techniques can detect a minuscule number of occult cancer cells.
Although relationships between lymphatic invasion and lymph
node micrometastasis in gastric cancer have been identified, the
presence of lymphatic invasion has been based on the routine
histological HE staining (Cai et al, 2000; Matsumoto et al, 2002).
Since specific lymphatic endothelial markers have not been
available, the accuracy of such findings has remained contro-
versial. The D2-40 monoclonal antibody has been reported to
recognise an oncofetal antigen present in fetal germ cells (Marks
et al, 1999). And, this monoclonal antibody D2-40 can selectively
detect lymphatic vessels (Kahn et al, 2002; Kahn and Marks, 2002;
Fogt et al, 2004) as it can differentiate a fixation-resistant epitope
on a 40kDa O-linked sialoglycoprotein that is expressed in
lymphatic endothelium but not in blood vessels (Kahn et al,
2002). That is, D2-40 staining is immunonegative in endothelial
cells of blood and it have been applicable to evaluate the presence
or absence of lymphatic invasion in various malignant neoplasms
(Kahn and Marks, 2002). However, relationships between lymph
node micrometastasis and clinicopathological findings have not
been reported, including lymphatic invasion based on D2-40
immunohistochemical staining.
The purpose of the present study was to investigate the presence
of lymph node micrometastasis using RT–PCR in patients who
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swere diagnosed with pN0 gastric cancer by routine histological
examination. In addition, we analysed the relationship between
lymph node micrometastasis and clinicopathological findings,
especially that of lymphatic invasion re-evaluated by monoclonal
antibody D2-40 staining.
MATERIALS AND METHODS
Patients
We enrolled 80 patients who were diagnosed with pN0 gastric
cancer according to routine histological examination with HE
staining. All patients underwent curative gastrectomy with
lymphadenectomy at the Department of Surgical Oncology and
Digestive Surgery, Kagoshima University Hospital, between
February 2003 and January 2005. None of the patients had
received preoperative radiation therapy or chemotherapy. In all, 50
patients underwent distal gastrectomy, five proximal, 12 total and
13 partial gastrectomy. Based on the rules of the Japanese
classification of gastric cancer (Japanese Gastric Cancer Associa-
tion, 1998), the patients underwent D1 (n¼21), D2 (n¼6) or
modified D2 (removal of all perigastric nodes and other nodes
along the left gastric artery, common hepatic artery and celiac
artery; n¼53) lymphadenectomy. Table 1 shows the clinicopatho-
logical data of the 57 male and 23 female patients (age range, 41–
84 years; average, 65 years) assessed according to the Japanese
classification of gastric cancer (Japanese Gastric Cancer Associa-
tion, 1998). The stomach was divided into U (upper), M (middle)
and L (lower) thirds where 12, 45 and 23 tumours developed,
respectively. The tumours were histopathologically classified as
differentiated (papillary, well differentiated, moderately differen-
tiated (tubular adenocarcinomas; n¼39) or undifferentiated
(poorly differentiated adenocarcinoma, mucinous adenocarcinoma
and signet-ring cell carcinoma; n¼41).
Lymph nodes
We examined 1862 lymph nodes obtained from the 80 patients
described above. The mean number of dissected lymph nodes was
23 (range, 2–69). Positive controls were lymph nodes from 10
patients whose gastric cancer was accompanied by histologically
evident metastasis. Negative controls were lymph nodes from 15
patients without cancer (six gall bladder stones, four gastric
adenomas, four gastric ulcers and one Crohn’s disease). The lymph
nodes were cut into 2 blocks at the plane of the largest dimension.
Half of each lymph node was suspended in 1ml of Isogen (Nippon
Gene, Toyama, Japan) and immediately stored at  801C. The
remaining halves were fixed in 10% formaldehyde, embedded in
paraffin, sliced into 3mm sections and stained with HE. Other
sections were stained for immunohistochemistry (IHC) using
cytokeratin (CK) monoclonal antibody. All specimens were
collected from the patients after informed consent had been
obtained in accordance with the institutional guidelines of our
hospital.
Immunohistochemistry
All lymph nodes were stained for IHC using a mouse monoclonal
antibody against human CK AE1/AE3 (DAKO Corporation,
Carpinteria, CA, USA). The sections were deparaffinised in xylene
and rehydrated in ethanol, and then endogenous peroxidase
activity was blocked by incubating the sections for 5min in 3%
hydrogen peroxide in methanol. The sections were then immersed
in proteinase K (DAKO Corporation, Carpinteria, CA, USA) to
activate the antigen and incubated with CK monoclonal antibody
diluted 1:200 for 30min. After two 5-min washes with phosphate-
buffered saline (PBS), the reactions for CK were developed with an
avidin–biotin complex immunoperoxidase technique (ABC method;
VECTASTAIN ABC kit, Vector Laboratories, Inc., Burlingame, CA,
USA). The sections were visualised using diaminobenzidine
tetrahydrochloride. The negative control consisted of sections
treated with the same protocol but with the primary antibody
omitted. Normal gastric mucosa and the primary tumours of the
specimens were used as positive controls and were consistently
positive for CK.
The resected primary tumours were immunostained with D2-40
monoclonal antibody (DAKO Corporation, Carpinteria, CA, USA),
fixed in 10% formalin and embedded in paraffin. Sectioned
specimens on slides were deparaffinised in xylene and rehydrated
with a graded series of ethanol. Endogenous peroxidase was
blocked by immersion in methanol containing 3% hydrogen
peroxide for 5min. After a 5-min wash with PBS, the nonspecific
binding was blocked in PBS containing 1% bovine serum albumin
at room temperature for 30min. The blocked sections were
incubated at 41C overnight with 50-fold diluted monoclonal
antibody D2-40 in PBS, and D2-40 binding was visualised using
an avidin–biotin complex immunoperoxidase procedure (Kahn
et al, 2002; Kahn and Marks, 2002).
Cell lines
MKN-45, an adenocarcinoma cell line that produces carcino-
embryonic antigen (CEA) derived from a gastric cancer, was
cultured in RPMI 1640 (Nissui Pharmaceutical Co., Ltd, Tokyo,
Japan) supplemented with 10% fetal calf serum (Mitsubishi Kasei,
Tokyo, Japan), 100Uml
 1 penicillin and 100Uml
 1 streptomycin.
Real-time RT–PCR
Thawed lymph nodes were homogenised using FastPrep (Qbio-
gene, Inc., Carlsbad, CA, USA) and then total RNA extracted
according to the manufacturer’s instructions was dissolved in 20ml
of water treated with diethylpyrocarbonate. The concentration,
purity and amount of total RNA were determined by measuring
absorption at 260 and 280nm using a GeneQuant pro UV/Vis
Spectrophotometer (Amersham Pharmacia Biotech, Cambridge,
England). To avoid contamination with genomic DNA, 0.5mgo f
Table 1 Clinicopathological findings of 80 patients with gastric cancer
Gender
Male 57
Female 23
Tumour location
Upper 12
Middle 45
Lower 23
Histological type
Differentiated 39
Undifferentiated 41
Depth of tumour invasion
pT1 74
pT2 6
Lymphatic invasion
a
Negative 71
Positive 9
Venous invasion
a
Negative 73
Positive 7
pT1¼invasion of mucosa or submucosa; pT2¼invasion of muscularis propria or
subserosa.
aLymphatic and venous invasion were identified based on haematoxylin–
eosin staining.
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stotal RNA was digested for 15min at 371C with 1U of DNase-I
(Invitrogen, Life technologies, Foster City, CA, USA) that was
subsequently inactivated by heating with 1mlo f2 5 m M ethylene-
diamine tetra-acetic acid (EDTA) at 651C for 15min. Complemen-
tary DNA (cDNA) was synthesised using the Advantaget RT-for
PCR Kit (Clontech Lab. Inc., Palo Alto, CA, USA) according to the
manufacturer’s protocol and then stored at  201C. A CEA-specific
oligonucleotide primer was designed based on that described by
Gerhard et al (1994) as follows: sense, 50-TGTCGGCATCAT
GATTGG-30and antisense, 50-GCAAATGCTTTAAGGAAGAAGC-
30. The donor and acceptor probe sequences for CEA identification
were 50-CCTGAAATGAAGAAACTACACCAGGGC-fluorescein and
50-LC-Red640-GCTATATCAGAGCAACCCCAACCAGC-phosphor-
ylation. CEA was amplified by PCR using a quantitative fluo-
rescence LightCyclert (Roche Diagnostics, Mannheim, Germany)
in a 20ml reaction mixture containing 2ml of LightCyclert
FastStart DNA Master Hybridization Probes (Roche), 3.0mM
MgCl2, 0.5mM sense and antisense primers, 0.4mM fluorescent
probe, 0.2mM LC-Red probe and 5ml of undiluted template cDNA
in LightCyclert capillaries (Roche). Before amplification, 0.32mlo f
anti-Taq DNA polymerase antibody (TaqStartt, Clontech Lab.
Inc.) was incubated with the reaction mixture at room temperature
for 5min to avoid primer prolongation. The amplification profile
consisted of one cycle at 951C for 10min (denaturation) followed
by 35 cycles of 951C for 10s, 601C for 15s and 721C for 5s. Real-
time PCR was monitored by measuring fluorescent signals at the
end of the annealing phase for each cycle. The background signals
were eliminated by setting the noise band in this study, and a
sample was classified as positive if the intensity of fluorescence
exceeded the noise band (Fit Points Method) (Marutsuka et al,
2003).
We quantified and confirmed the integrity of the RNA by
comparison with real-time RT–PCR of the amplified glyceralde-
hyde-3-phosphatase dehydrogenase (GAPDH) housekeeping gene.
The sense and antisense primers for GAPDH were 50-TGAACGG
GAAGCTCACTGG-30 and TCCACCACCCTGTTGCTGTA-30. The
donor and acceptor probes for GAPDH were 50-TCAACAGCGA
CACCCACTCCT-30-fluorescein and 50-LC-Red640-CACCTTT
GACGCTGGGGCT-30-phosphorylation. The GAPDH gene was
amplified in 20ml of the same reaction mixture as described above
in a LightCyclert capillary (Roche). The amplification profile
consisted of one cycle at 951C for 10min (denaturation) followed
by 45 cycles of 951C for 15s, 601C for 15s and 721C for 12s. All
primers and probes were synthesised and purified by reverse-
phase high-performance liquid chromatography and the optimal
reagent concentrations and PCR cycling conditions were estab-
lished by the Nihon Gene Research Laboratories (Sendai, Japan).
Each run of RT–PCR reaction included positive controls
synthesised from MKN-45 cells, negative controls from RNA-
negative samples. Real-time RT–PCR assays were repeated in
triplicate. Quantification data were analysed using the Light-
Cyclert software (Roche).
We tested the sensitivity of the RT–PCR assay by spiking a
series of 10-fold dilutions of MKN-45 cells (10
6–10
0) into 1 10
7
peripheral blood mononuclear cells (PBMCs) from a normal
healthy volunteer who did not express CEA mRNA. Total RNA
extracted as described above was assayed by real-time RT–PCR.
The RT–PCR product was identified by 2% agarose-gel electro-
phoresis in Tris-acetate EDTA buffer and visualised after staining
with ethidium bromide.
Statistical analysis
All statistical calculations were performed using StatView statis-
tical software version 5.5 (SAS Institute, Cary, NC, USA). All data
were statistically compared using the w
2 test. A P-value of o0.05
was considered statistically significant.
RESULTS
Sensitivity of RT–PCR and CEA mRNA expression in
control samples
CEA mRNA was detectable in MKN-45 cancer cell lines at
concentrations as low as 10
1 tumour cells per 10
7 PBMCs
(Figure 1). Although 10 lymph nodes from 10 patients with gastric
cancer accompanied by histologically evident metastasis expressed
CEA mRNA (positive control), none of 15 lymph nodes from 15
patients without cancer expressed CEA mRNA under the same
conditions (negative control, Table 2).
Incidence of lymph node micrometastasis by IHC and
RT–PCR
Lymph node micrometastasis was identified in nine of the 80
patients (11.3%) and in 34 of the 1862 nodes (1.8%) by IHC,
whereas RT–PCR revealed lymph node micrometastasis in 25
patients (31.3%) and 66 nodes (3.5%). Of these 66 lymph node
micrometastases, 33 were detected only by RT–PCR. On the other
hand, only one lymph node micrometastasis was detected by IHC
alone.
Diagnostic comparison of lymphatic invasion determined
by HE and D2-40 staining
Lymphatic vessels were clearly delineated by D2-40 staining
(Figure 2). The patient described in this figure had a pT2 tumour
that routine histological examination had determined was pN0 and
free of lymphatic invasion (Figure 2A). However, D2-40 staining
revealed obvious lymphatic invasion (Figure 2B). A single cancer
cell was identified by CK immunohistochemical staining in this
lymphatic vessel (Figure 2C). Some lymphatic vessels that were HE
negative were obviously positive according to D2-40 staining
(Figure 2). Histological HE staining revealed lymphatic invasion
from the primary tumour in nine of the 80 patients (11.3%,
Figure 3). In eight of these nine, lymphatic invasion detected by
HE staining was in accord with the results of D2-40 staining. On
the other hand, lymphatic invasion was newly detected in 11
(13.8%) patients who were diagnosed as free of lymphatic invasion
by HE staining. Thus, the incidence of lymphatic invasion
increased from 11.3% by HE staining to 23.8% by D2-40 staining.
Correlation between lymph node micrometastasis and
clinicopathological findings of patients with gastric cancer
With regard to the depth of tumour invasion, lymph node
micrometastasis was identified in 20 of 74 (27.0%) and in five of
six (83.3%) patients with pT1 with pT2 tumours, respectively. The
incidence of lymph node micrometastasis significantly differed
between pT1 and pT2 tumours even though fewer patients had pT2
tumours (P¼0.0042). However, significant difference was not
found in tumour location, histological type and venous invasion
(Table 3). Both HE (P¼0.0150) and D2-40 immunohistochemical
staining (Po0.0001) found a significantly higher incidence of
lymph node micrometastasis in patients with, than without
lymphatic invasion. However, lymph node micrometastasis more
closely correlated with D2-40 than with HE staining (Table 4).
DISCUSSION
Increasingly sensitive immunohistochemical and biological tech-
niques have recently led to the detection of lymph node
micrometastasis. Reports indicate that RT–PCR can detect lymph
node micrometastasis more sensitively than IHC (Mori et al, 1995;
Matsumoto et al, 2002). Here, we found lymph node micro-
metastasis in 11.3% of patients with pN0 gastric cancer according
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sto IHC, and in 31.3% according to RT–PCR. This means that
the lymphatic spread of occult cancer cells is beyond the limits of
detection by routine histological examination. Several reports have
described a relationship between lymph node micrometastasis and
clinicopathological characteristics in gastric cancer (Cai et al, 2000;
Matsumoto et al, 2002). Matsumoto et al (2002) reported that the
incidence of lymph node micrometastasis is significantly higher
in pN0 patients with lymphatic invasion than in those without
lymphatic invasion. However, lymphatic invasion was evaluated
only by conventional HE staining in these reports.
In the present study, the majority of patients (92.5%) had early
gastric tumour and they underwent the standard lymphadenec-
tomy. None of 80 enrolled patients died or recurred because of
short follow-up period within 2 years. Therefore, we could not find
the significant difference in survival rate according to the presence
or absence of lymph node micrometastasis. However, we think that
meticulous follow-up examination should be needed in patients
with lymph node micrometastasis for long period.
We used D2-40 staining to identify lymphatic vessels in the
present study. Kahn and Marks (2002) reported that D2-40
antibody could be useful to ascertain the presence or absence of
lymphatic invasion in various malignant neoplasms. They reported
that the false negative and false positive rates of HE staining in
breast cancer are 18 and 4%, respectively. Similarly, we found
higher detection rates with D2-40, compared with HE staining
(23.8 vs 11.3%). D2-40 staining newly revealed lymphatic invasion
in 11 of 71 patients (15.5%) in whom HE staining was negative.
These results indicated that lymphatic invasion could be pre-
sent in some patients who have been diagnosed as free of
lymphatic invasion by routine histological examination. Thus,
since diagnosis of lymphatic invasion was clearly enhanced by
D2-40 staining, it is necessary to examine lymphatic invasion by
D2-40 staining for accurate diagnosis, especially in early gastric
cancer.
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Figure 1 Sensitivity of real-time RT–PCR using CEA mRNA as the primer. (A) The intensity of fluorescence vs PCR cycles. (B) Ethidium bromide-stained
agarose gels following electrophoresis of CEA and GAPDH RT–PCR products. M¼DNA molecular weight marker.
Table 2 Expression of CEA mRNA in lymph nodes from patients with
and without gastric cancer
Expression of CEA mRNA
Lymph nodes Negative Positive Total
Metastatic lymph nodes of gastric cancer
a 01 0 1 0
Lymph nodes of benign disease 15 0 15
aThese lymph nodes were diagnosed with evident metastases by haematoxylin–
eosin staining.
Lymphatic invasion and micrometastasis in gastric cancer
T Arigami et al
691
British Journal of Cancer (2005) 93(6), 688–693 & 2005 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sD2-40 staining indicated that the incidence of lymph node
micrometastasis was significantly higher in patients with, than
without lymphatic invasion (Po0.0001). This finding demon-
strated that lymph node micrometastasis, which is the initial stage
of lymph node metastasis, is closely related to lymphatic invasion.
Figure 2 Example of a patient diagnosed as being free of lymphatic
invasion by routine histological examination. (A) Routine haematoxylin–
eosin staining. (B) D2-40 staining. (C) Cytokeratin (AE1/AE3) staining.
Original magnification  400.
Positive
9
Negative
71
Negative
1
Positive
8
Negative
60
Positive
11
HE staining
(patient samples)
D2-40 staining
(patient samples)
Figure 3 Diagnostic comparison of lymphatic invasion between
haematoxylin–eosin (HE) and D2-40 staining in 80 patients.
Table 3 Correlation between lymph node micrometastasis and clinico-
pathological findings
Micrometastasis (%)
Variables  (n¼55) +(n¼25) P-value
Tumour location
Upper 10 (83.3) 2 (16.7) 0.4935
Middle 30 (66.7) 15 (33.3)
Lower 15 (65.2) 8 (34.8)
Histological type
Differentiated 28 (71.8) 11 (28.2) 0.5666
Undifferentiated 27 (65.9) 14 (34.1)
Depth of tumour invasion
pT1 54 (73.0) 20 (27.0) 0.0042
pT2 1 (16.7) 5 (83.3)
Venous invasion
a
Negative 52 (71.2) 21 (28.8) 0.1218
Positive 3 (42.9) 4 (57.1)
pT1¼invasion of mucosa or submucosa; pT2¼invasion of muscularis propria or
subserosa.
aVenous invasion was identified based on haematoxylin–eosin staining.
Table 4 Correlation between lymph node micrometastasis and
lymphatic invasion
Micrometastasis (%)
Lymphatic invasion  (n¼55) +(n¼25) P-value
HE staining
Negative 52 (73.2) 19 (26.8) 0.0150
Positive 3 (33.3) 6 (66.7)
D2-40 staining
Negative 52 (85.2) 9 (14.8) o0.0001
Positive 3 (15.8) 16 (84.2)
HE¼haematoxylin–eosin.
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sEarly gastric cancer has recently been treated by endoscopic
mucosal resection (EMR) (Takekoshi et al, 1994). However, a
disadvantage of this approach is that imaging cannot accurately
diagnose lymph node micrometastasis. The clinical significance of
lymph node micrometastasis in gastric cancers remains contro-
versial (Ishida et al, 1997). Therefore, lymphatic invasion in
resected specimens should be examined not only by staining with
HE but also with D2-40 to predict lymph node micrometastasis.
The SN concept was originally advocated by Morton et al (1992)
to treat patients with melanoma. According to this concept, SN is
the first lymph node to receive lymphatic flow from the primary
tumour, and micrometastasis develops at this site. Lymph node
dissection areas can be accurately assessed by SNNS in patients
with breast cancer and malignant melanoma (Veronesi et al, 1997;
Edwards et al, 1998). The SN concept has recently been applied to
gastrointestinal tract cancers including gastric cancers (Saha et al,
2000; Aikou et al, 2001; Uenosono et al, 2003), but its clinical
application remains controversial. An assured diagnosis of lymph
node micrometastasis determined by RT–PCR is essential when
performing SNNS, since the clinical significance of lymph node
micrometastasis is also contentious (Ishida et al, 1997). It is
difficult to routinely assess micrometastasis in all dissected lymph
nodes using IHC and RT–PCR in the aspects of time consuming
and cost for practical use. Therefore, we should select the cases in
which the diagnosis of lymph node micrometastasis reflects the
operative procedure. Actually, we think that an intraoperative
diagnosis of micrometastasis is essential in SNNS. If SNNS
becomes acceptable for patients with gastric cancer in the near
future, then minimally invasive surgery with personalised lym-
phadenectomy might be safely performed in consideration of
lymph node micrometastasis.
In conclusion, we demonstrated that RT–PCR can sensitively
detect lymph node micrometastasis, and that D2-40 staining can
identify lymphatic invasion at a higher frequency than routine
histological HE staining. Lymph node micrometastasis, which is
the initial stage of lymph node metastasis, was closely related to
lymphatic invasion. Thus, information about micrometastasis and
lymphatic invasion obtained by RT–PCR and D2-40 staining will
be useful for considering less invasive treatment strategies such as
EMR or SNNS.
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